<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2023</study_start_year><data_sharing_plan>IPD Sharing (as of April 2023): Yes
Description: All IPD that underlie results in publication
Additional information available: Clinical Study Report</data_sharing_plan><condition>Adenocarcinoma</condition><condition>Stage III Colorectal Cancer</condition><condition>Adenocarcinoma of the Rectum</condition><condition>Colorectal Neoplasms</condition><condition>Stage II Colorectal Cancer</condition><condition>Stage I Colorectal Cancer</condition><condition>Adenocarcinoma of the Colon</condition><disease>Adenocarcinoma</disease><disease>Stage Ii Colorectal Cancer</disease><disease>Adenocarcinoma Of The Rectum</disease><disease>Colorectal Neoplasms</disease><disease>Stage Iii Colorectal Cancer</disease><disease>Adenocarcinoma Of The Colon</disease><disease>Stage I Colorectal Cancer</disease><study_type>Observational</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/2357375</full_dataset_link><location>United States</location><study_start_month>10</study_start_month><repository>ECRIN MDR</repository><study_status>Not yet recruiting</study_status></additional><is_claimable>false</is_claimable><name>The Utility and Feasibility of Mt-sDNA as a Surveillance Procedure in Colorectal Cancer Survivors</name><description>The purpose of this research study is to determine whether testing of stool for a panel of markers will enable us to detect polyps and cancer compared to standard testing.</description><dates><creation>2023-10-15</creation></dates><accession>2357375</accession><cross_references><ClinicalTrials___gov>NCT04624555</ClinicalTrials___gov></cross_references></HashMap>